Sign In
Get Clay Free →

Suggestions

    Laurene Redding

    Head, Value, Access & Policy at BeiGene

    Laurene Redding is an experienced global pharmaceutical executive currently serving as the Global Head of Value, Access & Pricing at BeiGene.12 With over 25 years of experience in progressively senior roles within the pharmaceutical industry, Redding has a unique breadth of knowledge in the field.2

    BeiGene is a global biotechnology company co-founded in 2010 by John Oyler, an American entrepreneur, and Dr. Xiaodong Wang, a world-renowned biochemist.1 The company focuses on developing and delivering cancer medicines to improve the lives of patients worldwide.1

    Redding's career spans both public and private healthcare sectors. She has worked as a health economic consultant, in the hospital system, and as the head of the pharmaceutical division of Canada's largest private insurer.1 Additionally, she has served as the industry representative on the Patented Medicines Prices Review Board (PMPRB), where she championed the industry's views on price reform and modernization.1

    At BeiGene, Redding continues to demonstrate the company's commitment to access and innovation in healthcare.3 Her extensive experience and leadership role position her as a key figure in shaping BeiGene's strategies for value, access, and pricing in the global pharmaceutical market.

    Related Questions

    What are Laurene Redding's main responsibilities at BeiGene?
    How has Laurene Redding's career evolved in the pharmaceutical industry?
    What are some notable projects Laurene Redding has worked on at BeiGene?
    How does Laurene Redding contribute to the global market access strategies at BeiGene?
    What are the key challenges Laurene Redding faces in her role at BeiGene?
    Laurene Redding
    Laurene Redding, photo 1
    Laurene Redding, photo 2
    Add to my network

    Location

    Canada